V003-7008 Screening compound: N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-2-phenoxyacetamide

V003-7008 Screening compound: N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-2-phenoxyacetamide
V003-7008 Screening compound: N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-2-phenoxyacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V003-7008
N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-2-phenoxyacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V003-7008

Molecular Formula

C30H30F2N4O2 (C30 H30 F2 N4 O2)

Compound Name

N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl]methyl}-2-phenoxyacetamide

IUPAC name

N-ethyl-N-{[1-(4-fluorophenyl)-5-[(4-fluorophenyl)methyl]-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl]methyl}-2-phenoxyacetamide

SMILES

CCN(Cc(c1c2CCN(Cc(cc3)ccc3F)C1)nn2-c(cc1)ccc1F)C(COc1ccccc1)=O

InChI

InChI=1S/C30H30F2N4O2/c1-2-35(30(37)21-38-26-6-4-3-5-7-26)20-28-27-19-34(18-22-8-10-23(31)11-9-22)17-16-29(27)36(33-28)25-14-12-24(32)13-15-25/h3-15H,2,16-21H2,1H3

InChI Key

YKLXNHBVMYSRPN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19859082

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

516.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.415

Distribution Coefficient, logD

1.165

Water Solubility, LogSw

-4.18

Polar Surface Area

41.632

Acid Dissociation Constant (pKa)

22.71

Base Dissociation Constant (pKb)

10.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.67

V003-7008 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V003-7008 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V003-7008?
Check Price and Availability of V003-7008, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V003-7008 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V003-7008
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V003-7008
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V003-7008 available by request